Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

A systematic approach is crucial for managing hair loss in women.

Hormonal therapies are safe and effective for treating adult women's acne.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

Immune cells affect hair growth and could lead to new hair loss treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.